Cargando…

Effectiveness of Antiseizure Medication Duotherapies in Patients With Glioma: A Multicenter Observational Cohort Study

BACKGROUND AND OBJECTIVES: About 30% of patients with glioma need an add-on antiseizure medication (ASM) due to uncontrolled seizures on ASM monotherapy. This study aimed to determine whether levetiracetam combined with valproic acid (LEV + VPA), a commonly prescribed duotherapy, is more effective t...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Meer, Pim B., Dirven, Linda, Fiocco, Marta, Vos, Maaike J., Kouwenhoven, Mathilde C.M., van den Bent, Martin J., Taphoorn, Martin J.B., Koekkoek, Johan A.F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519253/ https://www.ncbi.nlm.nih.gov/pubmed/36219797 http://dx.doi.org/10.1212/WNL.0000000000200807

Ejemplares similares

Effectiveness of Antiseizure Medication Triple Therapy in Patients With Glioma With Refractory Epilepsy: An Observational Cohort Study
por: van der Meer, Pim B., et al.
Publicado: (2023)

Impact of timing of antiseizure medication withdrawal on seizure recurrence in glioma patients: a retrospective observational study
por: van der Meer, Pim B., et al.
Publicado: (2023)

Retention rates of antiepileptic drugs in glioma patients: the most appropriate outcome
por: van der Meer, Pim B, et al.
Publicado: (2020)

First‐line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid
por: van der Meer, Pim B., et al.
Publicado: (2021)

First‐line levetiracetam versus enzyme‐inducing antiseizure medication in glioma patients with epilepsy
por: van der Meer, Pim B., et al.
Publicado: (2022)

The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamide
por: van Opijnen, Mark P., et al.
Publicado: (2021)

The Impact of the Timing of Health-Related Quality of Life Assessments on the Actual Results in Glioma Patients: A Randomized Prospective Study
por: Peeters, Marthe C.M., et al.
Publicado: (2020)

Effect of antiepileptic drugs in glioma patients on self-reported depression, anxiety, and cognitive complaints
por: van der Meer, Pim B., et al.
Publicado: (2021)

Prediagnostic presentations of glioma in primary care: a case–control study
por: Peeters, Marthe CM, et al.
Publicado: (2019)

Management of epilepsy in brain tumor patients
por: van der Meer, Pim B., et al.
Publicado: (2022)

Efficacy of antiepileptic drugs in glioma patients with epilepsy: a systematic review
por: de Bruin, Marjolein E, et al.
Publicado: (2021)

Research Objectives, Statistical Analyses and Interpretation of Health-Related Quality of Life Data in Glioma Research: A Systematic Review
por: Coomans, Marijke B., et al.
Publicado: (2020)

Prescription preferences of antiepileptic drugs in brain tumor patients: An international survey among EANO members
por: van der Meer, Pim B, et al.
Publicado: (2021)

Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide
por: Koekkoek, Johan A. F., et al.
Publicado: (2015)

Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study
por: Koekkoek, Johan A F, et al.
Publicado: (2014)

Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study
por: Kerkhof, M., et al.
Publicado: (2019)

Health-related quality of life in high-grade glioma patients
por: Dirven, Linda, et al.
Publicado: (2014)

Evaluating the lack of impact of the e-health application Oncokompas on outcomes in incurably ill cancer patients
por: Dirven, Linda, et al.
Publicado: (2022)

Is the EORTC QLQ‐C30 emotional functioning scale appropriate as an initial screening measure to identify brain tumour patients who may possibly have a mood disorder?
por: Oort, Quirien, et al.
Publicado: (2022)

Targeting Oxidative Stress with Antioxidant Duotherapy after Experimental Traumatic Brain Injury
por: Kyyriäinen, Jenni, et al.
Publicado: (2021)

Depression and anxiety in glioma patients
por: van der Meer, Pim B, et al.
Publicado: (2023)

Advance care planning in glioblastoma patients: development of a disease-specific ACP program
por: Fritz, Lara, et al.
Publicado: (2019)

Neurocognitive impairment and patient–proxy agreement on health-related quality of life evaluations in recurrent high-grade glioma patients
por: Caramanna, Ivan, et al.
Publicado: (2022)

Does early resection of presumed low-grade glioma improve survival? A clinical perspective
por: Wijnenga, Maarten M. J., et al.
Publicado: (2017)

Antiepileptic drug treatment in the end-of-life phase of glioma patients: a feasibility study
por: Koekkoek, Johan A. F., et al.
Publicado: (2015)

Long-Term Disease Burden and Survivorship Issues After Surgery and Radiotherapy of Intracranial Meningioma Patients
por: Zamanipoor Najafabadi, Amir H, et al.
Publicado: (2020)

The long-term caregiver burden in World Health Organization grade I and II meningioma: It is not just the patient
por: Zamanipoor Najafabadi, Amir H, et al.
Publicado: (2020)

Determinants and predictors for the long-term disease burden of intracranial meningioma patients
por: Zamanipoor Najafabadi, Amir H., et al.
Publicado: (2020)

Long-Term Disease Burden and Survivorship Issues After Surgery and Radiotherapy of Intracranial Meningioma Patients
por: Zamanipoor Najafabadi, Amir H, et al.
Publicado: (2021)

The impact of current treatment modalities on the outcomes of patients with melanoma brain metastases: A systematic review
por: van Opijnen, Mark P., et al.
Publicado: (2019)

Frequency and burden of potentially treatable symptoms in glioma patients with stable disease
por: Röttgering, Jantine G., et al.
Publicado: (2023)

Individual changes in neurocognitive functioning and health-related quality of life in patients with brain oligometastases treated with stereotactic radiotherapy
por: van der Meer, Pim B., et al.
Publicado: (2018)

EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
por: Weller, Michael, et al.
Publicado: (2020)

Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients
por: Dirven, Linda, et al.
Publicado: (2021)

Advance Care Planning in Glioblastoma Patients
por: Fritz, Lara, et al.
Publicado: (2016)

Author Correction: EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
por: Weller, Michael, et al.
Publicado: (2022)

Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors
por: Lassman, Andrew B., et al.
Publicado: (2022)

Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics
por: Synhaeve, Nathalie E., et al.
Publicado: (2018)

Teratogenicity and Antiseizure Medications
por: Meador, Kimford
Publicado: (2020)

Antiseizure medications and pregnancy
por: Moores, Ginette, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5e5cae1287js733n8ocf0kieuv